Jacqueline Doody

8.0k total citations · 7 hit papers
34 papers, 6.5k citations indexed

About

Jacqueline Doody is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Jacqueline Doody has authored 34 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 13 papers in Oncology and 5 papers in Organic Chemistry. Recurrent topics in Jacqueline Doody's work include TGF-β signaling in diseases (10 papers), Angiogenesis and VEGF in Cancer (6 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Jacqueline Doody is often cited by papers focused on TGF-β signaling in diseases (10 papers), Angiogenesis and VEGF in Cancer (6 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Jacqueline Doody collaborates with scholars based in United States and Spain. Jacqueline Doody's co-authors include Joan Massagué, Marcus Kretzschmar, Juan M. Cárcamo, Luis Ulloa, Jeffrey L. Wrana, Akiko Hata, Alejandro Zentella‐Dehesa, Marikki Laiho, Liliana Attisano and Xiao-Fan Wang and has published in prestigious journals such as Nature, Cell and Journal of Biological Chemistry.

In The Last Decade

Jacqueline Doody

33 papers receiving 6.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

TGFβ signals through a heteromeric protein kinase receptor complex

1992 1.3k citations Jeffrey L. Wrana, Liliana Attisano et al. Cell profile →
A mechanism of repression of TGFbeta / Smad signaling by oncogenic Ras

1999 844 citations Marcus Kretzschmar, Jacqueline Doody et al. profile →
Opposing BMP and EGF signalling pathways converge on the TGF-β family mediator Smad1

1997 740 citations Marcus Kretzschmar, Jacqueline Doody et al. Nature profile →
Inhibition of transforming growth factor-β/SMAD signalling by the interferon-γ/STAT pathway

1999 692 citations Jacqueline Doody, Joan Massagué et al. Nature profile →
A human Mad protein acting as a BMP-regulated transcriptional activator

1996 578 citations Fang Liu, Akiko Hata et al. Nature profile →
Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-β receptor system

1991 546 citations Fernando López‐Casillas, Sela Cheifetz et al. Cell profile →
Human Type II Receptor for Bone Morphogenic Proteins (BMPs): Extension of the Two-Kinase Receptor Model to the BMPs

1995 504 citations Fang Liu, Francesc Ventura et al. Molecular and Cellular Biology profile →

Peers

Countries citing papers authored by Jacqueline Doody

Since Specialization

Citations

This map shows the geographic impact of Jacqueline Doody's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacqueline Doody with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacqueline Doody more than expected).

Fields of papers citing papers by Jacqueline Doody

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacqueline Doody. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacqueline Doody. The network helps show where Jacqueline Doody may publish in the future.

Co-authorship network of co-authors of Jacqueline Doody

This figure shows the co-authorship network connecting the top 25 collaborators of Jacqueline Doody. A scholar is included among the top collaborators of Jacqueline Doody based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacqueline Doody. Jacqueline Doody is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	FS118, a Bispecific Antibody Targeting LAG-3 and PD-L1, Enhances T-Cell Activation Resulting in Potent Antitumor Activity 2020 ·Clinical Cancer Research ·Matthew Kraman, Mustapha Faroudi, (unknown), (unknown), Daniel Gliddon, (unknown), Alexander Koers, Mateusz Wydro, Sarah Batey, (unknown), Lesley Young, (unknown), Jacqueline Doody, Michelle Morrow, Neil Brewis	82
2	Generation of Fcabs targeting human and murine LAG-3 as building blocks for novel bispecific antibody therapeutics 2018 ·Methods ·Katy L. Everett, Matthew Kraman, (unknown), (unknown), (unknown), Miguel Gaspar, (unknown), (unknown), Jacqueline Doody, (unknown)	22
3	Antitumor Activity of IMC-038525, a Novel Oral Tubulin 2010 ·Translational Oncology ·M. Carolina Tuma, Asra Malikzay, Xiaohu Ouyang, David Surguladze, James Fleming, (unknown), (unknown), Bridget Finnerty, Jacqueline Doody, Eugene L. Piatnitski Chekler, Paul Kussie, James R. Tonra	28
4	Tumor Necrosis Factor-α and Interleukin-1 Antagonists Alleviate Inflammatory Skin Changes Associated with Epidermal Growth Factor Receptor Antibody Therapy in Mice 2009 ·Cancer Research ·David Surguladze, Dhanvanthri S. Deevi, (unknown), Erik Corcoran, Su Wang, Mary Jane Plym, Yan Wu, Jacqueline Doody, David J. Mauro, Larry Witte, Klaus J. Busam, (unknown), Ulrich Rodeck, James R. Tonra	40
5	Synthesis and evaluation of heteroaryl-ketone derivatives as a novel class of VEGFR-2 inhibitors 2008 ·Bioorganic & Medicinal Chemistry Letters ·Eugene L. Piatnitski Chekler, (unknown), Alexander S. Kiselyov, (unknown), Xiaohu Ouyang, Ki Hyun Kim, Ying Wang, Yaron R. Hadari, Jacqueline Doody	9
6	Arylphthalazines as potent, and orally bioavailable inhibitors of VEGFR-2 2008 ·Bioorganic & Medicinal Chemistry ·Matthew A. J. Duncton, Eugene L. Piatnitski Chekler, (unknown), (unknown), Wai C. Wong, Leon M. Smith, Joel K. Kawakami, Alexander S. Kiselyov, Daniel L. Milligan, (unknown), Yaron R. Hadari, Ying Wang, Sheetal Patel, (unknown), James R. Tonra, David Surguladze, (unknown), Paul Kussie, Peter Böhlen, Jacqueline Doody	34
7	Novel tricyclic azepine derivatives: Biological evaluation of pyrimido[4,5-b]-1,4-benzoxazepines, thiazepines, and diazepines as inhibitors of the epidermal growth factor receptor tyrosine kinase 2006 ·Bioorganic & Medicinal Chemistry Letters ·Leon M. Smith, Wai C. Wong, Alexander S. Kiselyov, (unknown), (unknown), Yong‐Jiang Xu, Matthew A. J. Duncton, Ki Hyun Kim, Evgueni L. Piatnitski, Jacqueline Doody, Ying Wang, (unknown), Daniel L. Milligan, John Columbus, (unknown), (unknown), (unknown), Yaron R. Hadari	25
8	Arylphthalazines: Identification of a new phthalazine chemotype as inhibitors of VEGFR kinase 2005 ·Bioorganic & Medicinal Chemistry Letters ·Evgueni L. Piatnitski, Matthew A. J. Duncton, Alexander S. Kiselyov, (unknown), (unknown), Daniel L. Milligan, (unknown), Wai C. Wong, Joel K. Kawakami, Jacqueline Doody	44
9	Arylphthalazines. Part 2: 1-(Isoquinolin-5-yl)-4-arylamino phthalazines as potent inhibitors of VEGF receptors I and II 2005 ·Bioorganic & Medicinal Chemistry Letters ·Matthew A. J. Duncton, Evgueni L. Piatnitski, (unknown), Leon M. Smith, Alexander S. Kiselyov, Daniel L. Milligan, (unknown), Wai C. Wong, Joel K. Kawakami, Jacqueline Doody	30
10	Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability. 2002 ·PubMed ·Fang Liao, Jacqueline Doody, Jay Overholser, Bridget Finnerty, Rajiv Bassi, Yan Wu, Elisabetta Dejana, Paul Kussie, Peter Böhlen, Daniel J. Hicklin	86
11	Opposing BMP and EGF signalling pathways converge on the TGF-β family mediator Smad1 breakdown → 1997 ·Nature ·Marcus Kretzschmar, Jacqueline Doody, (unknown)	740
12	A human Mad protein acting as a BMP-regulated transcriptional activator breakdown → 1996 ·Nature ·Fang Liu, Akiko Hata, Julie C. Baker, Jacqueline Doody, Juan M. Cárcamo, Richard M. Harland, Joan Massagué	578
13	Interaction of Transforming Growth Factor-β Receptor I with Farnesyl-protein Transferase-α in Yeast and Mammalian Cells 1996 ·Journal of Biological Chemistry ·Francesc Ventura, Fang Liu, Jacqueline Doody, Joan Massagué	47
14	Human Type II Receptor for Bone Morphogenic Proteins (BMPs): Extension of the Two-Kinase Receptor Model to the BMPs breakdown → 1995 ·Molecular and Cellular Biology ·Fang Liu, Francesc Ventura, Jacqueline Doody, Joan Massagué	504
15	TGFβ signals through a heteromeric protein kinase receptor complex breakdown → 1992 ·Cell ·Jeffrey L. Wrana, Liliana Attisano, Juan M. Cárcamo, Alejandro Zentella‐Dehesa, Jacqueline Doody, Marikki Laiho, Xiao-Fan Wang, Joan Massagué	1346
16	Role of prolactin in growth of the rat mammary tumor MTW9 1991 ·International Journal of Cancer ·(unknown), Jacqueline Doody, John Mandeli, Vincent P. Hollander	4
17	Signal transduction and gene expression in Dictyostelium discoideum 1991 ·Developmental Genetics ·Robert P. Dottin, Sobha R. Bodduluri, Jacqueline Doody, Bodduluri Haribabu	14
18	Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-β receptor system breakdown → 1991 ·Cell ·Fernando López‐Casillas, Sela Cheifetz, Jacqueline Doody, Janet Andres, William S. Lane, Joan Massagué	546
19	Signal transduction pathways involved in the expression of the uridine diphosphoglucose pyrophosphorylase gene of Dictyostelium discoideum 1991 ·Developmental Genetics ·Bodduluri Haribabu, Jovan Pavlovic, Sobha R. Bodduluri, Jacqueline Doody, Benjamin Ortiz, (unknown), Byoung C. Moon, Robert P. Dottin	4
20	Characterization by Chromatofocusing of Estrogen Receptors From Rat Mammary Tumor MTW9 1989 ·JNCI Journal of the National Cancer Institute ·(unknown), Jacqueline Doody, (unknown), (unknown), Vincent P. Hollander	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact